Cara Therapeutics | CARA - 税引前利益





税引前利益 変化する 日付
Acadia Pharmaceuticals USD 46.47M 42.49M 2026-06
Alterity Therapeutics Limited AUD -6.26M 1.52M 2025-12
Cara Therapeutics USD -6.8M 1.9M 2026-03
Cassava Sciences USD -10.81M 33.41M 2025-09
Chugai Pharma JPY 169.02B 8.83B 2026-06
Cipla INR 10.82B 3.33B 2026-06
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD -7.66M 64.51M 2026-03
CSL USD 2.61B 1.21B 2025-12
Grifols EUR 257.85M 190.87M 2024-12
Halozyme Therapeutics USD 180.33M 281.18M 2026-03
J&J USD 8.66B 839M 2026-06
Neurocrine Biosciences USD 246.8M 7.4M 2026-03
Pacira USD 5M 4.43M 2026-03
Pfizer USD -653M 5.84B 2026-06
RedHill Biopharma USD -1.54M 12M 2024-06
Supernus Pharmaceuticals USD -57.65M 51.7M 2026-06
Vanda Pharmaceuticals USD -22.92M 16.68M 2024-12